Sagie Shira, Edni Omer, Weinberg Joseph, Toubiana Shir, Kozlovski Tal, Frostig Tzviel, Katzin Nirit, Bar-Am Irit, Selig Sara
Molecular Medicine Laboratory, Rambam Health Care Campus and Rappaport Faculty of Medicine, Technion, Haifa 31096, Israel.
Department of Statistics and Operations Research, The Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv 39040, Israel.
Hum Mol Genet. 2017 Nov 1;26(21):4244-4256. doi: 10.1093/hmg/ddx313.
Mutations in the de novo DNA methyltransferase DNMT3B lead to Immunodeficiency, Centromeric Instability and Facial anomalies (ICF) syndrome, type I. This syndrome is characterized, among other hypomethylated genomic loci, by severe subtelomeric hypomethylation that is associated with abnormally short telomere length. While it was demonstrated that the mean telomere length is significantly shorter in ICF type I cells, it is unknown whether all telomeres are equally vulnerable to shortening. To study this question we determined by combined telomere-FISH and spectral karyotyping the relative length of each individual telomere in lymphoblastoid cell lines (LCLs) generated from multiple ICF syndrome patients and control individuals. Here we confirm the short telomere lengths, and demonstrate that telomere length variance in the ICF patient group is much larger than in the control group, suggesting that not all telomeres shorten in a uniform manner. We identified a subgroup of telomeres whose relatively short lengths can distinguish with a high degree of certainty between a control and an ICF metaphase, proposing that in ICF syndrome cells, certain individual telomeres are consistently at greater risk to shorten than others. The majority of these telomeres display high sequence identity at the distal 2 kb of their subtelomeres, suggesting that the attenuation in DNMT3B methylation capacity affects individual telomeres to different degrees based, at least in part, on the adjacent subtelomeric sequence composition.
从头DNA甲基转移酶DNMT3B的突变会导致I型免疫缺陷、着丝粒不稳定和面部异常(ICF)综合征。除其他低甲基化基因组位点外,该综合征的特征是严重的亚端粒低甲基化,这与异常短的端粒长度相关。虽然已证明I型ICF细胞中的平均端粒长度明显较短,但尚不清楚所有端粒是否同样容易缩短。为了研究这个问题,我们通过端粒-FISH和光谱核型分析相结合的方法,确定了来自多名ICF综合征患者和对照个体的淋巴母细胞系(LCLs)中每个端粒的相对长度。在这里,我们证实了端粒长度较短,并表明ICF患者组中端粒长度的差异远大于对照组,这表明并非所有端粒都以相同的方式缩短。我们鉴定出了一个端粒亚组,其相对较短的长度能够高度准确地区分对照中期和ICF中期,这表明在ICF综合征细胞中,某些单个端粒始终比其他端粒更容易缩短。这些端粒中的大多数在其亚端粒的远端2 kb处显示出高度的序列同一性,这表明DNMT3B甲基化能力的减弱至少部分地基于相邻亚端粒序列组成,对单个端粒产生不同程度的影响。